GAINESVILLE, Ga., Sept. 11, 2017 /PRNewswire/ -- Authentidate Holding Corp. (ADAT), a growth oriented company focused on developing and providing clinically actionable medical information and telemedicine services, announced today that David C. Goldberg, a former executive of Enzo Biochem, Inc, has joined the Company as its new Chief Operating Officer. As COO, Mr. Goldberg will have overall responsibility for the Company's operations on a worldwide basis.
Mr. Goldberg, 60, is a 35-year veteran of the life sciences and health care industries. He joins Aeon after recently completing an extended stint at Enzo where he held numerous executive and managerial positions across the company's operations, including President and General Manager of its clinical laboratory and research products divisions, leading both during major transitions in their business strategies. He has extensive expertise across the range of life sciences corporate functions including operations, marketing and sales, compliance, investor relations, and strategic planning. Prior to joining Enzo, Mr. Goldberg held marketing and management positions with both NEN Life Sciences, (now Perkin Elmer) and Gallard Schlesinger Chemical Manufacturing (now Budenheim USA).
"All of us at Aeon Global Health are excited and enthusiastic about having David join our family," said Sonny Roshan, Aeon's Founder, Chairman and CEO. Over the past eighteen months, our team has worked tirelessly to lay the foundation needed to morph our Company into an emerging leader in medical informatics, while dealing with the ardent tasks that came with our reverse merger into Authentidate. I am proud to say that we have made substantial progress and are now beginning to execute on our plan. Bringing David to Aeon signals the formal launch of this initiative. His leadership skills, industry knowledge and track record of successes bode well for Aeon in both the short and long term", he added.
"I am looking forward to my new role with the utmost of excitement", said Mr. Goldberg. "The Aeon Global team is a dynamic, highly skilled group of professionals, backed by outstanding resources, including a 30,000-square foot state of the art building that has been built to the highest standards, a robust molecular-based research and development facility, and access to intellectual property in both the diagnostic and information technology spaces. We have already begun the process of vetting the myriad of opportunities that have been presented to Aeon, and as a result, expect to report on a number of developments and enhancements to the Company in the near term."
ABOUT AUTHENTIDATE/AEON GLOBAL HEALTH
Authentidate Holding Corp. (ADAT), through its Aeon Global Health operating arm, is an emerging leader in the provision of clinically actionable medical informatics. Founded in 2010, Aeon is focused on the delivery of services consistent with federal quality standards and which exceed industry standards for turn-around time. Operating out of a modern 30,000 square-foot facility in suburban Atlanta, the Company provides a comprehensive menu of diagnostic and laboratory- developed tests as well as interpretative data for a wide range of inherited conditions.
Except for historical information, the matters discussed in this press release may be considered "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this release, words such as "believe", anticipate" think", "intend", "plan", "will be", "expect" or similar expressions identify such forward looking statements. In addition, such statements include declarations regarding the intent, belief or current expectations of Authentidate Holding Corp. and its management, including those related to cash flow, gross margins, revenues, and expenses which are dependent on a number of factors outside of the control of the Company including, for example, the markets for the Company's services, costs of and services, other expenses, government regulations, litigation, and general business conditions. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and thatactual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control. Other risks and uncertainties are more fully described in our reports filed with the SEC. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The statements made in this press release speak only as of the date stated herein, and subsequent events and developments may cause our expectations and beliefs to change. Unless otherwise required by applicable securities laws, we do not intend, nor do we undertake any obligation, to update or revise any forward-looking statements contained in this news release to reflect subsequent information, events, results or circumstances or otherwise.